KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Total Debt (2016 - 2025)

Historic Total Debt for Halozyme Therapeutics (HALO) over the last 14 years, with Q3 2025 value amounting to $1.5 billion.

  • Halozyme Therapeutics' Total Debt rose 43.9% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 43.9%. This contributed to the annual value of $1.5 billion for FY2024, which is 43.69% up from last year.
  • Halozyme Therapeutics' Total Debt amounted to $1.5 billion in Q3 2025, which was up 43.9% from $1.5 billion recorded in Q2 2025.
  • Halozyme Therapeutics' Total Debt's 5-year high stood at $1.5 billion during Q3 2025, with a 5-year trough of $89.0 million in Q1 2021.
  • For the 5-year period, Halozyme Therapeutics' Total Debt averaged around $1.1 billion, with its median value being $1.5 billion (2023).
  • Per our database at Business Quant, Halozyme Therapeutics' Total Debt skyrocketed by 301444.56% in 2021 and then crashed by 45.53% in 2023.
  • Quarter analysis of 5 years shows Halozyme Therapeutics' Total Debt stood at $876.7 million in 2021, then skyrocketed by 71.8% to $1.5 billion in 2022, then dropped by 0.45% to $1.5 billion in 2023, then rose by 0.44% to $1.5 billion in 2024, then rose by 0.33% to $1.5 billion in 2025.
  • Its Total Debt was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.